Literature DB >> 28515323

β-Adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure.

Micah B Schott1, Karuna Rasineni2, Shaun G Weller1, Ryan J Schulze1, Arthur C Sletten3, Carol A Casey2,4, Mark A McNiven5.   

Abstract

In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the β-adrenergic (β-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to β-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the β-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). β-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this β-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in β-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in both PKA activation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that β-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.

Entities:  

Keywords:  G protein-coupled receptor (GPCR); adipose triglyceride lipase (ATGL); adrenergic receptor; alcohol; cyclic AMP (cAMP); fatty liver; hepatocyte; lipid droplet

Mesh:

Substances:

Year:  2017        PMID: 28515323      PMCID: PMC5512075          DOI: 10.1074/jbc.M117.777748

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets.

Authors:  D L Brasaemle; D M Levin; D C Adler-Wailes; C Londos
Journal:  Biochim Biophys Acta       Date:  2000-01-17

2.  Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase.

Authors:  Yong Wu; Ping Song; Jian Xu; Miao Zhang; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2007-01-25       Impact factor: 5.157

3.  Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis.

Authors:  Guenter Haemmerle; Robert Zimmermann; Marianne Hayn; Christian Theussl; Georg Waeg; Elke Wagner; Wolfgang Sattler; Thomas M Magin; Erwin F Wagner; Rudolf Zechner
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

Review 4.  6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme.

Authors:  S J Pilkis; T H Claus; I J Kurland; A J Lange
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

5.  Inhibition of hepatic gluconeogenesis by ethanol.

Authors:  H A Krebs; R A Freedland; R Hems; M Stubbs
Journal:  Biochem J       Date:  1969-03       Impact factor: 3.857

6.  Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis.

Authors:  Brendan N Reid; Gene P Ables; Oleg A Otlivanchik; Gabriele Schoiswohl; Rudolf Zechner; William S Blaner; Ira J Goldberg; Robert F Schwabe; Streamson C Chua; Li-Shin Huang
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

7.  The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism.

Authors:  Yinfang Wang; Yahui Zhang; Hang Qian; Juan Lu; Zhifeng Zhang; Xinwen Min; Mingjian Lang; Handong Yang; Nanping Wang; Peng Zhang
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

8.  ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling.

Authors:  Salmaan Ahmed Khan; Aishwarya Sathyanarayan; Mara T Mashek; Kuok Teong Ong; Edith E Wollaston-Hayden; Douglas G Mashek
Journal:  Diabetes       Date:  2015-02       Impact factor: 9.461

9.  β-Adrenergic agonist and antagonist regulation of autophagy in HepG2 cells, primary mouse hepatocytes, and mouse liver.

Authors:  Benjamin L Farah; Rohit A Sinha; Yajun Wu; Brijesh K Singh; Jin Zhou; Boon-Huat Bay; Paul M Yen
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

10.  Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice.

Authors:  Rotonya M Carr; Giselle Peralta; Xiaoyan Yin; Rexford S Ahima
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more
  27 in total

1.  Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism.

Authors:  Paul G Thomes; Karuna Rasineni; Li Yang; Terrence M Donohue; Jacy L Kubik; Mark A McNiven; Carol A Casey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-04       Impact factor: 4.052

Review 2.  Role and mechanisms of autophagy in alcohol-induced liver injury.

Authors:  Xiaojuan Chao; Wen-Xing Ding
Journal:  Adv Pharmacol       Date:  2019-02-24

Review 3.  Alcohol: basic and translational research; 15th annual Charles Lieber &1st Samuel French satellite symposium.

Authors:  Manuela G Neuman; Helmut K Seitz; Pamela L Tuma; Natalia A Osna; Carol A Casey; Kusum K Kharbanda; Lawrence B Cohen; Steve D H Malnick; Raghabendra Adhikari; Ramyajit Mitra; Raghubendra Singh Dagur; Murali Ganesan; Chava Srinivas; Arumugam Madan Kumar; Moses New-Aaron; Larisa Poluektova; Paul G Thomes; Karuna Rasineni; Mihai Opris; Rolf Teschke
Journal:  Exp Mol Pathol       Date:  2022-02-19       Impact factor: 4.401

4.  Alcohol-induced microtubule acetylation leads to the accumulation of large, immobile lipid droplets.

Authors:  Jennifer L Groebner; Marlene T Girón-Bravo; Mia L Rothberg; Raghabendra Adhikari; Dean J Tuma; Pamela L Tuma
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-02       Impact factor: 4.052

Review 5.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

6.  KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL.

Authors:  Cody N Rozeveld; Katherine M Johnson; Lizhi Zhang; Gina L Razidlo
Journal:  Cancer Res       Date:  2020-08-19       Impact factor: 12.701

Review 7.  Lipid Droplet Formation and Lipophagy in Fatty Liver Disease.

Authors:  Ryan J Schulze; Mark A McNiven
Journal:  Semin Liver Dis       Date:  2019-04-30       Impact factor: 6.115

8.  Maturation of Lipophagic Organelles in Hepatocytes Is Dependent Upon a Rab10/Dynamin-2 Complex.

Authors:  Zhipeng Li; Shaun G Weller; Kristina Drizyte-Miller; Jing Chen; Eugene W Krueger; Bridget Mehall; Carol A Casey; Hong Cao; Mark A McNiven
Journal:  Hepatology       Date:  2020-03-25       Impact factor: 17.425

9.  The small GTPase Rab32 resides on lysosomes to regulate mTORC1 signaling.

Authors:  Kristina Drizyte-Miller; Jing Chen; Hong Cao; Micah B Schott; Mark A McNiven
Journal:  J Cell Sci       Date:  2020-06-11       Impact factor: 5.285

10.  Crosstalk between beta-adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high-fat diet-fed male mice.

Authors:  Sadia Ashraf; Nadia Ashraf; Gizem Yilmaz; Romain Harmancey
Journal:  Physiol Rep       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.